title: Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation.
abstract: OBJECTIVE
  A retrospective study of primary biliary cirrhosis (PBC) was performed to study the Original Mayo Model for predicting survival by a Dutch data-set of patients, presentation of disease progression; assessment of liver transplantation, prediction of post-transplantation survival; and the addition of two laboratory variables to the Original Mayo Model.
  
  
  METHODS
  Survival of 83 patients, 37 of whom underwent transplantation, were studied. Mean follow-up was 6.0 +/- 0.45 SEM years. Risk score at diagnosis, platelet count, and serum sodium were analyzed in a Cox model.
  
  
  RESULTS
  The Original Mayo Model estimated survival for low-, medium-, and high-risk groups accurately and it also presented disease progression. Baseline Mayo risk score in a Cox model had a regression coefficient of 1.01, indicating an excellent predictor p < 0.0001. Platelet count was a predictor of survival (p < 0.002), whereas serum sodium did not (p = 0.67). A new model combined of the Original Mayo risk score and platelet count predicted survival in high-risk patients somewhat better compared to the Original Mayo Model. With both models, liver transplantation had a significant beneficial effect on survival (p < 0.001). The scores revealed no significant influence (p = 0.47) for overall post-transplantation survival.
  
  
  CONCLUSIONS
  The Original Mayo Model remains the model of choice for patients with PBC for prognostication from 3-8 years, is a useful tool in the assessment of liver transplantation but not an indicator of post-transplantation survival. Platelet count showed to have additional prognostic value. A new model combined of platelet count and the Original Mayo risk score did predict survival in high-risk groups slightly better compared to the Original Mayo Model.
authors.affiliation: International School of Hepatology and Tropical Medicine GISH-T, Faculty of Medical Science, State University of Groningen, The Netherlands.
authors.forename: G M
authors.initials: GM
authors.lastname: van Dam
authors.forename: B W
authors.initials: BW
authors.lastname: Verbaan
authors.forename: T M
authors.initials: TM
authors.lastname: Therneau
authors.forename: E R
authors.initials: ER
authors.lastname: Dickson
authors.forename: M
authors.initials: M
authors.lastname: Malinchoc
authors.forename: P A
authors.initials: PA
authors.lastname: Murtaugh
authors.forename: J R
authors.initials: JR
authors.lastname: Huizenga
authors.forename: C H
authors.initials: CH
authors.lastname: Gips
mesh_terms: D000328:Adult; D018450:Disease Progression; D005260:Female; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000097:blood / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011379:Prognosis; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D012964:Sodium / Q000097:blood; D015996:Survival Rate
chemical_list: D012964:Sodium